Hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer: current evidence-based indications

被引:0
作者
Pareja, Rene [1 ,2 ,3 ]
机构
[1] Clin ASTORGA, Dept Gynecol, Gynecol Oncol, Medellin, Colombia
[2] Inst Nacl Cancerol, Bogota, Colombia
[3] Clin ASTORGA, Gynecology, Gynecol Oncol, Medellin, Colombia
关键词
Ovarian Neoplasms; Ovarian Cancer;
D O I
10.1136/ijgc-2022-004244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:841 / 842
页数:2
相关论文
共 5 条
[1]   Current and future trials about HIPEC in ovarian cancer [J].
Ghirardi, Valentina ;
Trozzi, Rita ;
Scambia, Giovanni ;
Fagotti, Anna .
BULLETIN DU CANCER, 2024, 111 (03) :254-260
[2]   Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer A Randomized Clinical Trial [J].
Lim, Myong Cheol ;
Chang, Suk-Joon ;
Park, Boram ;
Yoo, Heon Jong ;
Yoo, Chong Woo ;
Nam, Byung Ho ;
Park, Sang-Yoon .
JAMA SURGERY, 2022, 157 (05) :374-383
[3]   Is there a role for hyperthermic intraperitoneal chemotherapy in ovarian cancer? [J].
Praiss, Aaron M. ;
Moukarzel, Lea A. ;
Zivanovic, Oliver .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2023, 35 (01) :21-26
[4]  
van Driel WJ, 2018, NEW ENGL J MED, V378, P1363, DOI 10.1056/NEJMc1802033
[5]   Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study [J].
Zivanovic, Oliver ;
Chi, Dennis S. ;
Zhou, Qin ;
Iasonos, Alexia ;
Konner, Jason A. ;
Makker, Vicky ;
Grisham, Rachel N. ;
Brown, Amy K. ;
Nerenstone, Stacy ;
Diaz, John P. ;
Schroeder, Eric D. ;
Langstraat, Carrie L. ;
Paroder, Viktoriya ;
Lakhman, Yulia ;
Soldan, Krysten ;
Su, Katy ;
Gardner, Ginger J. ;
Andikyan, Vaagn ;
Guo, Jianxia ;
Jewell, Elizabeth L. ;
Roche, Kara Long ;
Troso-Sandoval, Tiffany ;
Lichtman, Stuart M. ;
Moukarzel, Lea A. ;
Dessources, Kimberly ;
Abu-Rustum, Nadeem R. ;
Aghajanian, Carol ;
Tew, William P. ;
Beumer, Jan ;
Sonoda, Yukio ;
O'Cearbhaill, Roisin E. .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (23) :2594-+